UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Management of Paclitaxel-Induced Hand-Foot Syndrome

Breast care (Basel, Switzerland), 2013-06, Vol.8 (3), p.215-217

2013

Volltextzugriff (PDF)

Management of Paclitaxel-induced hand-foot syndrome

Breast care (Basel, Switzerland), 2013, Vol.8 (3), p.215-217

2013

Volltextzugriff (PDF)

Observation of coupling between zero- and two- dimensional semiconductor systems based on anomalous diamagnetic effects

Nano research, 2016-02, Vol.9 (2), p.306-316

2016

Volltextzugriff (PDF)

High‐Responsivity Photodetection by a Self‐Catalyzed Phase‐Pure p‐GaAs Nanowire

Small (Weinheim an der Bergstrasse, Germany), 2018-04, Vol.14 (17), p.e1704429-n/a

2018

Volltextzugriff (PDF)

Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase

Hematology (Luxembourg), 2024-12, Vol.29 (1), p.2329027-2329027

2024

Volltextzugriff (PDF)

Foot gangrene following Tagraxofusp treatment for blastic plasmacytoid dendritic cell neoplasm: Case report

EJHaem, 2022-11, Vol.3 (4), p.1374-1376

2022

Volltextzugriff (PDF)

The successful use of FLT3 inhibitors in FLT3-positive mixed phenotype acute leukemia

Leukemia & lymphoma, 2020-11, Vol.61 (13), p.3275-3277

2020

Volltextzugriff (PDF)

Hemophagocytosis arising during disease progression of chronic myelomonocytic leukemia

International journal of laboratory hematology, 2022-02, Vol.44 (1), p.25-26

2022

Volltextzugriff (PDF)

Combination treatment with CPX‐351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature

British journal of haematology, 2020-08, Vol.190 (3), p.467-470

2020

Volltextzugriff (PDF)

PB2248: BONE MARROW NECROSIS: RARE PRESENTATION OF CHRONIC MYELOID NEOPLASMS SYSTEMIC REVIEW AND CASE REPORT

HemaSphere, 2023-08, Vol.7 (S3), p.e658196e-n/a

2023

Volltextzugriff (PDF)

Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

Bone marrow transplantation (Basingstoke), 2021-08, Vol.56 (8), p.1908-1918

2021

Volltextzugriff (PDF)

P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE

HemaSphere, 2023-08, Vol.7 (S3), p.e071333e-n/a

2023

Volltextzugriff (PDF)

Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study

British journal of haematology, 2017-12, Vol.179 (5), p.781-789

2017

Volltextzugriff (PDF)

Acute Lymphoblastic Leukemia in Patients 60 Years and Older Treated with Pediatric-Inspired Protocols, 20 Years of Follow-up

Blood, 2022-11, Vol.140 (Supplement 1), p.3176-3177

2022

Volltextzugriff (PDF)

Outcome of ALL in Adult Patient with Down Syndrome, Single Center Experience

Blood, 2022-11, Vol.140 (Supplement 1), p.3187-3188

2022

Volltextzugriff (PDF)

Which Asparaginase Formulation Retained Higher VTE Incidence Risk in Post Treatment Adult Acute Lymphoblastic Leukemia? a Meta-Analysis

Blood, 2022-11, Vol.140 (Supplement 1), p.8898-8899

2022

Volltextzugriff (PDF)

Germline Testing for Patients with Familial MPN: A Single-Center Experience

Blood, 2022-11, Vol.140 (Supplement 1), p.6879-6880

2022

Volltextzugriff (PDF)

Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia

Haematologica (Roma), 2024-02, Vol.109 (2), p.671-675

2024

Volltextzugriff (PDF)

Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen

EJHaem, 2023-02, Vol.4 (1), p.232-235

2023

Volltextzugriff (PDF)

Prophylaxis with low‐molecular‐weight heparin reduces thrombotic events and allows continuation of asparaginase containing regimens during intensification phase

British journal of haematology, 2022-04, Vol.197 (2), p.e32-e34

2022

Volltextzugriff (PDF)

Safety and Efficacy of JAK Inhibitor Therapy in BCR-ABL Negative MPN Patients with Underlying Portal Hypertension

Blood, 2021-11, Vol.138 (Supplement 1), p.3652-3652

2021

Volltextzugriff (PDF)

Osteolytic lesion in polycythemia vera: First report and review of literature

EJHaem, 2022-05, Vol.3 (2), p.526-532

2022

Volltextzugriff (PDF)

Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol

Leukemia, 2024-04, Vol.38 (4), p.912-913

2024

Volltextzugriff (PDF)

Real-World Outcomes and Adverse Events of Elderly Patients with Ph-Negative Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Protocol

Blood, 2022-11, Vol.140 (Supplement 1), p.6039-6041

2022

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(138)

Publikationsform

Artikel
(153)
Berichte
(3)

Sprache

Englisch
(156)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(53)
Clinical Lymphoma, Myeloma And Leukemia
(8)
British Journal Of Haematology
(6)
Leukemia
(5)
Blood Advances
(4)
Ejhaem
(4)
Hemasphere
(4)
Journal Of Clinical Oncology
(4)
Leukemia & Lymphoma
(4)
American Journal Of Hematology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Management of Paclitaxel-Induced Hand-Foot Syndrome

Management of Paclitaxel-induced hand-foot syndrome

Observation of coupling between zero- and two- dimensional semiconductor systems based on anomalous diamagnetic effects

High‐Responsivity Photodetection by a Self‐Catalyzed Phase‐Pure p‐GaAs Nanowire

Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase

Foot gangrene following Tagraxofusp treatment for blastic plasmacytoid dendritic cell neoplasm: Case report

The successful use of FLT3 inhibitors in FLT3-positive mixed phenotype acute leukemia

Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients

Hemophagocytosis arising during disease progression of chronic myelomonocytic leukemia

Combination treatment with CPX‐351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature

PB2248: BONE MARROW NECROSIS: RARE PRESENTATION OF CHRONIC MYELOID NEOPLASMS SYSTEMIC REVIEW AND CASE REPORT

Prognostic impact of the adverse molecular-genetic profile on long-term outcomes following allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE

Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study

Acute Lymphoblastic Leukemia in Patients 60 Years and Older Treated with Pediatric-Inspired Protocols, 20 Years of Follow-up

Outcome of ALL in Adult Patient with Down Syndrome, Single Center Experience

Which Asparaginase Formulation Retained Higher VTE Incidence Risk in Post Treatment Adult Acute Lymphoblastic Leukemia? a Meta-Analysis

Germline Testing for Patients with Familial MPN: A Single-Center Experience

Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia

Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen

Prophylaxis with low‐molecular‐weight heparin reduces thrombotic events and allows continuation of asparaginase containing regimens during intensification phase

Safety and Efficacy of JAK Inhibitor Therapy in BCR-ABL Negative MPN Patients with Underlying Portal Hypertension

Osteolytic lesion in polycythemia vera: First report and review of literature

Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol

Real-World Outcomes and Adverse Events of Elderly Patients with Ph-Negative Acute Lymphoblastic Leukemia Treated with a Pediatric-Inspired Protocol

Suchergebnisse filtern